Tag: Shawn Yu
GSK to acquire Chimagen asset in deal worth up to USD750m
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million